Published online April 1, 2005
PEDIATRICS Vol. 115 No. 4 April 2005, pp. 1103-1106 (doi:10.1542/peds.2005-0085)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Related Collections
Right arrow Therapeutics & Toxicology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

POLICY STATEMENT

Use of Performance-Enhancing Substances

Committee on Sports Medicine and Fitness

Performance-enhancing substances include dietary supplements, prescription medications, and illicit drugs. Virtually no data are available on the efficacy and safety in children and adolescents of widely used performance-enhancing substances. This statement is intended to provide a generalized but functional definition of performance-enhancing substances. The American Academy of Pediatrics strongly condemns the use of performance-enhancing substances and vigorously endorses efforts to eliminate their use among children and adolescents.


Key Words: ergogenic • anabolic • performance enhancing • banned substance • athlete • adolescent • sport



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Statement of reaffirmation:

AAP Publications Reaffirmed and Retired, February and May 2008
Pediatrics 122: 450-450. [Full Text]



This article has been cited by other articles:


Home page
CLIN PEDIATRHome page
J. W. Berg, M. J. Mehlman, D. B. Rubin, and E. Kodish
Making All the Children Above Average: Ethical and Regulatory Concerns for Pediatricians in Pediatric Enhancement Research
Clinical Pediatrics, June 1, 2009; 48(5): 472 - 480.
[Abstract] [PDF]


Home page
Journal of Sport and Social IssuesHome page
B. Stewart and A. C.T. Smith
Drug Use in Sport: Implications for Public Policy
Journal of Sport and Social Issues, August 1, 2008; 32(3): 278 - 298.
[Abstract] [PDF]


Home page
PediatricsHome page
Council on Sports Medicine and Fitness
Strength Training by Children and Adolescents
Pediatrics, April 1, 2008; 121(4): 835 - 840.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
Committee on Sports Medicine and Fitness
Promotion of Healthy Weight-Control Practices in Young Athletes
Pediatrics, December 1, 2005; 116(6): 1557 - 1564.
[Abstract] [Full Text] [PDF]


Home page
AAP NewsHome page
G. McConnell
Getting an edge?: Long-term health effects of performance-enhancing supplements unknown, AAP policy warns
AAP News, April 1, 2005; 26(4): 1 - 11.
[Full Text] [PDF]